A breast cancer charity says a new report that identifies a multi-million dollar funding gap for medicines is a damning indictment of a failing system and an urgent wake-up call for change.
The report by the New Zealand Institute of Economic Research (NZIER) has found that medicines funding has fallen in real terms every year since 2007 to the point where there is now an investment gap of more than $680 million.
Researchers have discovered that women with breast cancer have far less of a particular bacterial species in their breast tissue than healthy women.
The new study, published in the journal Oncotarget, found that breast tissue in women with breast cancer contained far less Methylobacterium.
Ten-year results from a major breast cancer clinical trial suggest that routinely removing the axillary lymph nodes during lumpectomy to remove early-stage breast cancer may not be necessary.
The study was published in the journal JAMA and examined nearly 900 women diagnosed with early-stage breast cancer to find out if axillary node dissection lead to better long-term outcomes.
The Breast Cancer Aotearoa Coalition (BCAC) is thrilled to see a proposed extension of the upper age for free breast screening from 69 to 74-years-old in the Labour-New Zealand First coalition agreement.
The move is one of the key details for health outlined in the coalition agreement. At the moment, BreastScreen Aotearoa only offers free breast screening to women between the ages of 45 and 69.
Pinc & STEEL PaddleOn is a stand-up paddle (SUP) rehabilitation programme, for men and women recovering from all types of cancer.
Delivered over five weeks by certified Pinc or STEEL cancer rehabilitation physiotherapists, PaddleOn has been specifically designed to introduce the components of stand-up paddling in a safe, fun small group environment on the water.
Researchers have reviewed the evidence on early menopause in breast cancer patients and have come up with a series of recommendations to safely manage this side-effect.
The recommendations are published in The Journal of Clinical Endocrinology and Metabolism and are the result of a review of a number of clinical trials, observational studies and guidelines.
A breakthrough breast cancer drug can now be used in New Zealand, but the Breast Cancer Aotearoa Coalition (BCAC) is calling for Ibrance (palbociclib) to be publicly funded immediately.
MedSafe NZ has just approved the use of Ibrance for those with advanced hormone receptor positive and HER2-negative breast cancer, but it’s only available to those who can pay for it.
A new study has found that annual mammograms beginning at age 40 prevent the greatest number of breast cancer deaths.
The research from Weill Cornell Medicine investigators was published in the journal Cancer and found that annual screening beginning at age 40 resulted in 40% fewer breast cancer deaths.
A new study has found that moderate-to-vigorous physical activity can help to allay fatigue and “chemo brain” in breast cancer patients and survivors.
The University of Illinois research looked at the association between physical activity, fatigue and performance on cognitive tasks in nearly 300 breast cancer survivors.
Scientists have discovered a new stem cell-based cancer treatment that can target and kill breast cancer cells that have spread in mice.
The researchers at the University of California Irvine (UCI) also hope that the new treatment may prevent some of the toxic side-effects of chemotherapy by providing a more localised therapy.
